IGF2 and breast carcinoma: It has been reported that breast cancer-secreted miR-122 reprograms lung fibroblast aerobic glycolysis and thus promotes metastasis (20), and it was discovered that cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression (21).